Latest News in the pharma Industry

Top Stories

Shire Announces Top-line Results of Prevent2 Phase-III Trial of MMX Mesalamine

Shire Announces Top-line Results of Prevent2 Phase-III Trial of MMX Mesalamine

5 Apr 2012

Shire has revealed that it does not plan to pursue a regulatory filing for MMX mesalamine in patients with a history of diverticulitis, after the drug failed to meet the primary endpoint in a recent phase-III study.

Read more 
Merck Announces Publication of Phase-III Data for Shingles Vaccine Zostavax

Merck Announces Publication of Phase-III Data for Shingles Vaccine Zostavax

5 Apr 2012

Efficacy and safety data that supported the US FDA's expanded indication for Zostavax in 2011 have been published in Clinical Infectious Diseases.

Read more 
Catalent & BASF Form Bioavailability Alliance

Catalent & BASF Form Bioavailability Alliance

5 Apr 2012

The companies will combine their expertise to provide a range of services to address pipeline challenges with BCS Class II and IV poorly bioavailable compounds.

Read more 
Lonza Names New CEO

Lonza Names New CEO

5 Apr 2012

Richard Ridinger has been named chief executive officer of Lonza and will take over the role on May 1.

Read more 
Charles River & Metabolon Ink Biomarker Pact

Charles River & Metabolon Ink Biomarker Pact

5 Apr 2012

The cooperation combines Charles River’s preclinical oncology study expertise with Metabolon’s analysis of metabolic data to identify both mechanism of action and biomarkers.

Read more 
AKESOgen & London Genetics International Form Alliance

AKESOgen & London Genetics International Form Alliance

30 Mar 2012

The two firms will collaborate to help biopharma companies take advantage of pharmacogenetic solutions, including novel biomarker and assay development services.

Read more 
Sinovac Biotech Announces Director Appointment

Sinovac Biotech Announces Director Appointment

30 Mar 2012

Sinovac Biotech has announced the appointment of Mr. Meng Mei as an independent director. The appointment enables Sinovac to comply with NASDAQ Listing Rule 5605 requirement.

Read more 
Almac & Affymetrix Ink Distribution Pact

Almac & Affymetrix Ink Distribution Pact

30 Mar 2012

Almac has entered into an agreement with Affymetrix for Xcel Array distribution.

Read more 
SCM Pharma Wins Science & Technology Award

SCM Pharma Wins Science & Technology Award

30 Mar 2012

SCM Pharma was named the winner of the Science & Technology Award at the North East Business Award for the UK’s Northumberland and Tyneside region.

Read more 
Seaside Therapeutics Obtains Patent for Autism Drug Candidate STX209

Seaside Therapeutics Obtains Patent for Autism Drug Candidate STX209

29 Mar 2012

Seaside Therapeutics has obtained a US patent covering its lead product candidate STX209 for the improvement of social and communication functions in autism spectrum disorders.

Read more 
Bayer HealthCare & Tsinghua Expand Drug Discovery Pact

Bayer HealthCare & Tsinghua Expand Drug Discovery Pact

28 Mar 2012

Scientists from Tsinghua University will work with Bayer scientists to solve the 3D protein structure of biological molecular targets as a basis for new drug discovery projects.

Read more 
Impax & Tolmar Ink Supply Pact

Impax & Tolmar Ink Supply Pact

28 Mar 2012

The two firms have signed a multi-product deal for the development, supply and distribution of alternative dosage form products.

Read more